$266 Thousand is the total value of UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's 52 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 100.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
MUFG | Exit | MITSUBISHI UFJ FINL GRP INC | $0 | – | -167 | -100.0% | 0.00% | – |
UBS | Exit | UBS GROUP AG | $0 | – | -67 | -100.0% | 0.00% | – |
KOF | Exit | COCA-COLA FEMSA SAB-SP ADR | $0 | – | -14 | -100.0% | 0.00% | – |
PBRA | Exit | PETROLEO BRASIL SP PREF ADRnot used | $0 | – | -83 | -100.0% | 0.00% | – |
AEG | Exit | AEGON N.V.-AMERICAN REG ADR | $0 | – | -136 | -100.0% | 0.00% | – |
BABA | Exit | ALIBABA GROUP HOLDING LTD | $0 | – | -8 | -100.0% | 0.00% | – |
ERJ | Exit | EMBRAER SA | $0 | – | -90 | -100.0% | 0.00% | – |
UL | Exit | UNILEVER N.V. | $0 | – | -16 | -100.0% | 0.00% | – |
BUD | Exit | ANHEUSER-BUSCH INBEV SA/NV | $0 | – | -13 | -100.0% | 0.00% | – |
HMC | Exit | HONDA MOTOR CO LTD (ADR) | $0 | – | -25 | -100.0% | 0.00% | – |
ENIC | Exit | ENEL CHILE SA-ADR | $0 | – | -423 | -100.0% | 0.00% | – |
NVS | Exit | NOVARTIS AG | $0 | – | -14 | -100.0% | 0.00% | – |
ABEV | Exit | AMBEV SA | $0 | – | -231 | -100.0% | 0.00% | – |
E | Exit | ENI S P A | $0 | – | -25 | -100.0% | 0.00% | – |
WPP | Exit | WPP PLC NEW/ADRnot used | $0 | – | -15 | -100.0% | 0.00% | – |
TTE | Exit | TOTAL SA-SPON ADR | $0 | – | -14 | -100.0% | 0.00% | – |
Exit | GSK PLC-SPON ADR | $0 | – | -29 | -100.0% | 0.00% | – | |
GRFS | Exit | GRIFOLS SA-ADR | $0 | – | -107 | -100.0% | 0.00% | – |
SNY | Exit | SANOFI-AVENTIS | $0 | – | -23 | -100.0% | 0.00% | – |
SAP | Exit | SAP SE SHS | $0 | – | -7 | -100.0% | 0.00% | – |
ORAN | Exit | ORANGE SPON ADR | $0 | – | -91 | -100.0% | 0.00% | – |
CS | Exit | CREDIT SUISSE GP SP ADR | $0 | – | -168 | -100.0% | 0.00% | – |
TAK | Exit | TAKEDA PHARMACEUTIC | $0 | – | -137 | -100.0% | -0.00% | – |
GOOG | Exit | ALPHABET INC | $0 | – | -5,350 | -100.0% | -0.19% | – |
VIR | Exit | VIR BIOTECHNOLOGY INC | $0 | – | -130,409 | -100.0% | -0.94% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
TEXAS INSTRUMENTS INC | 41 | Q3 2023 | 31.2% |
PORTLAND GENERAL ELECTRIC CO | 38 | Q3 2023 | 0.0% |
LEXICON PHARMACEUTICALS INC | 33 | Q3 2023 | 1.7% |
AEGLEA BIOTHERAPEUTICS INC | 27 | Q2 2023 | 11.0% |
APOLLO ENDOSURGERY INC | 24 | Q1 2023 | 5.6% |
PLX PHARMA INC | 23 | Q1 2023 | 1.7% |
VANGUARD MSCI EMERGING MKTS | 22 | Q2 2019 | 10.3% |
VANGUARD ENERGY ETF | 22 | Q2 2019 | 8.7% |
VANGUARD S&P 500 ETF | 21 | Q3 2023 | 11.8% |
VANGUARD MSCI EAFE ETF | 20 | Q2 2019 | 13.1% |
View UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Taysha Gene Therapies, Inc. | September 24, 2021 | 1,156,255 | 3.0% |
ZIOPHARM ONCOLOGY INC | February 12, 2016 | 9 | 0.0% |
View UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
4 | 2024-05-01 |
3 | 2024-04-30 |
13F-HR | 2024-04-30 |
144 | 2024-04-29 |
SC 13G | 2024-03-05 |
13F-HR | 2024-02-28 |
SC 13G | 2024-02-14 |
13F-HR | 2023-11-09 |
13F-HR | 2023-08-04 |
3 | 2023-06-02 |
View UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.